Afshin Mahmoudi is a co-founder at Yatiri Bio and serves as a VP of Business Development. Mr. Mahmoudi is an accomplished pharmaceutical professional with over 20 years of comprehensive experience in drug discovery, small and large molecules, management and…

Pilgrim Jackson, Ph.D. co-founded Yatiri Bio in 2020 and currently serves as CEO. Prior to founding Yatiri Bio Dr. Jackson worked at Celgene for 13 years where he built and lead multidisciplinary teams to tackle challenging drug discovery problems in the areas of inflammation and oncology.…

Raman Afshar serves as the Vice President of Commercial and R&D at AnaSpec, Inc. since 2015 and is responsible for the company’s new product development, marketing campaigns, and worldwide sales. Raman earned a PhD in Inorganic Chemistry from the…

Dr. James Sorrentino is a computational biologist specializing in network modeling, machine learning, and context aware analysis of multi omics datasets. As Senior Scientist at Yatiri Bio, he develops statistical and ML driven frameworks that integrate proteomics with other…

Dr. Salvador Martinez is a bioinformatics leader with 22 years of experience developing advanced computational solutions for proteomics data management, analysis, and integration. As Head of Bioinformatics at Yatiri Bio, he designs and implements software platforms and analytical pipelines…

Dr. Antonius Koller brings over 20 years of expertise in LC/MS‑based proteomics and has worked at some of the world’s top academic research institutions. He currently serves as Head of Proteomics at Yatiri Bio, where he directs the company’s…

Mahan Abbasian is a biotechnology leader with nearly two decades of drug discovery experience in protein expression, characterization, and assay development. As Chief Operating Officer and Co Founder of Yatiri Bio, he oversees operational strategy, platform development, and partnerships…

Sam Tahmassebi has over 20 years of experience representing startup companies in intellectual property and transactional matters. His expertise is in the prosecution of patent applications, counseling on IPstrategy, invalidity and non-infringement opinions, IPdue diligence in relation to mergers…

Dr. Gregory Hannum is Principal Bioinformatics Scientist at Exact Sciences, specializing in AI driven biologics design and functional protein modeling. Formerly VP of AI Research at Absci and Co-Founder & CSO of Denovium, he pioneered deep learning platforms that…

Professor Van Eyk is a renowned international scientist in the field of clinical proteomics and serves as the Erika Glazer Chair in Women’s Heart Health, the Director of Advanced Clinical Biosystems Institute in the Department of Biomedical Sciences, the…

Dr. Robert Pierce is a physician–scientist with deep expertise in cancer immunology and translational biomarker development. He currently serves as Chief Medical Officer (consulting) at Attivare Therapeutics and previously as the company’s Chief Scientific Officer, advancing an immunostimulatory scaffold…

Dr. Mesirov is Associate Vice Chancellor for Computational Health Sciences and Professor of Medicine (Division of Medical Genetics) at UC San Diego School of Medicine and Moores Cancer Center, and a Senior Institute Fellow at the Broad Institute. She…

Dr. Afshin Bahador is a board-certified gynecologic and surgical oncologist specializing in robotic-assisted surgery for ovarian, uterine, cervical, and other gynecologic cancers. A fellowship-trained OB GYN, he earned his medical degree, completed residency, and trained in gynecologic oncology at…

Derek L. Stirewalt is a Professor in the Translational Science & Therapeutics Division at Fred Hutchinson Cancer Center and Associate Professor, Hematology & Oncology at the University of Washington — where he leads the Fred Hutch/UW Hematopoietic Diseases Repository, a national toll gate for AML…

Mike Breider, D.V.M., Ph.D. is a Board Certified Veterinary Pathologist with extensive experience as a manager and scientist in various aspects of Drug Discovery and Development.  Recently retired, Mike’s last position was with Celgene Pharmaceuticals as the Head of Exploratory Toxicology…

John R. Yates is the Ernest W. Hahn Professor in the Departments of Molecular Medicine and Neurobiology at The Scripps Research Institute. His research interests include development of integrated methods for tandem mass spectrometry analysis of protein mixtures, bioinformatics…

Greg Reyes, M.D., Ph.D. has over 30 years of experience as a senior leader in biotech and large pharma exploring drug discovery and development in multiple therapy areas.   His leadership positions included leading Drug Discovery for Celgene Corporation and…

Mr. Sai Rangarao is a senior biopharmaceutical commercial leader with two decades of experience launching and scaling therapeutic portfolios in neurology, oncology, immunology, and rare disease. He is currently Chief Commercial Officer at Pelthos Therapeutics and serves on the…

Michael J. Kamdar is a seasoned life science & healthcare executive with over 30 years of international leadership experience. He is an industry veteran that has done over $1B in business deals and raised more than $450M from venture…

Dr. Garret Hampton is a recognized leader in translational oncology, clinical genomics, and precision medicine with over three decades of experience integrating molecular biology, biomarker science, and advanced diagnostics. Most recently, he served as President of Clinical Next Generation…

Dr. Carl Goldfischer has 30 years of investment, and his background includes extensive public and private investment and transaction work, as well as clinical trial development knowledge. From 2000 until 2020 he was a partner and member of the…

Dr. Emily Chen is an accomplished academic and scientific leader with over 15 years of experience in translational research, biomarker discovery, and proteomics innovation. She currently works as a Business Consultant at ECI Lifescience Consulting, advising biotech companies on…

Dr. Bradley Gordon is a senior life science executive and entrepreneur with over 25 years of leadership experience spanning venture capital, corporate finance, business development, and biopharmaceutical operations. He is currently President and CEO of Katmai Pharmaceuticals, an academic…

Jen Turbiak Carroll is a senior communications and investor relations strategist with over two decades of experience elevating the visibility of leading life sciences and genomics companies. She most recently led communications and investor relations at Telesis Bio, where…

Dr. Webb is currently CEO of Synbal(www.synbal.com), Chairman of the Board at Agragene (www.agragene/com)and Adjunct Professor at The Scripps Research Institute (TSRI).  He was Chairman of the Board of Sorrento Therapeutics from 2012-2014and is also former chairman of the…